Absci to Participate in the KeyBanc Capital Markets Healthcare Forum
Absci (Nasdaq: ABSI), a data-first generative AI drug creation company, has announced its participation in the upcoming virtual KeyBanc Capital Markets Healthcare Forum. The company's management will engage in a fireside chat scheduled for Wednesday, March 19th, 2025 at 9:00 a.m. Eastern Time (6:00 a.m. Pacific Time). Investors and interested parties can access both live and archived webcasts of the presentation through Absci's investor relations website at investors.absci.com.
Absci (Nasdaq: ABSI), un'azienda che utilizza l'intelligenza artificiale generativa per la creazione di farmaci, ha annunciato la sua partecipazione al prossimo Healthcare Forum virtuale di KeyBanc Capital Markets. La direzione dell'azienda parteciperà a una chiacchierata informale programmata per mercoledì 19 marzo 2025 alle 9:00 ora orientale (6:00 ora pacifica). Gli investitori e le parti interessate possono accedere sia alle trasmissioni in diretta che a quelle archiviate della presentazione attraverso il sito web delle relazioni con gli investitori di Absci all'indirizzo investors.absci.com.
Absci (Nasdaq: ABSI), una empresa de creación de fármacos basada en inteligencia artificial generativa, ha anunciado su participación en el próximo Healthcare Forum virtual de KeyBanc Capital Markets. La dirección de la empresa participará en una charla informal programada para el miércoles 19 de marzo de 2025 a las 9:00 a.m. hora del Este (6:00 a.m. hora del Pacífico). Los inversores y partes interesadas pueden acceder tanto a las transmisiones en vivo como a las archivadas de la presentación a través del sitio web de relaciones con inversores de Absci en investors.absci.com.
Absci (Nasdaq: ABSI), 데이터 중심의 생성 AI 약물 개발 회사가 다가오는 가상 KeyBanc Capital Markets Healthcare Forum에 참여한다고 발표했습니다. 회사 경영진은 2025년 3월 19일 수요일 오전 9시 동부 표준시(오전 6시 태평양 표준시)에 예정된 대담에 참여할 것입니다. 투자자 및 관심 있는 분들은 Absci의 투자자 관계 웹사이트인 investors.absci.com을 통해 발표의 실시간 및 아카이브 웹캐스트에 접근할 수 있습니다.
Absci (Nasdaq: ABSI), une entreprise de création de médicaments basée sur l'intelligence artificielle générative, a annoncé sa participation au prochain Healthcare Forum virtuel de KeyBanc Capital Markets. La direction de l'entreprise participera à une discussion informelle prévue pour le mercredi 19 mars 2025 à 9h00, heure de l'Est (6h00, heure du Pacifique). Les investisseurs et les parties intéressées peuvent accéder aux webcasts en direct et archivés de la présentation via le site web des relations avec les investisseurs d'Absci à l'adresse investors.absci.com.
Absci (Nasdaq: ABSI), ein datengestütztes Unternehmen zur Generierung von KI-gestützten Arzneimitteln, hat seine Teilnahme am bevorstehenden virtuellen Healthcare Forum von KeyBanc Capital Markets bekannt gegeben. Das Management des Unternehmens wird an einem informellen Gespräch teilnehmen, das für Mittwoch, den 19. März 2025 um 9:00 Uhr Eastern Time (6:00 Uhr Pacific Time) geplant ist. Investoren und Interessierte können sowohl auf die Live- als auch auf die archivierten Webcasts der Präsentation über die Investor-Relations-Website von Absci unter investors.absci.com zugreifen.
- None.
- None.
VANCOUVER, Wash. and NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming virtual KeyBanc Capital Markets Healthcare Forum.
Absci management is scheduled to participate in a fireside chat on Wednesday, March 19th at 9:00 a.m. Eastern Time (6:00 a.m. Pacific Time). Interested parties may access a live and archived webcast on the company’s investor relations website at: investors.absci.com.
About Absci
Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug Creation™ platform unlocks the potential to accelerate time to clinic and increase the probability of success by simultaneously optimizing multiple drug characteristics important to both development and therapeutic benefit. With the data to train, the AI to create, and the wet lab to validate, we can screen billions of cells per week, allowing us to go from AI-designed candidates to wet lab-validated candidates in as little as six weeks. Absci’s headquarters is in Vancouver, WA, with our AI Research Lab in New York City and an Innovation Center in Zug, Switzerland. Visit www.absci.com and follow us on LinkedIn (@absci), X (Twitter) (@Abscibio), and YouTube.
Investor Contact
Alex Khan
VP, Finance & Investor Relations
investors@absci.com
Media Contact
press@absci.com
FAQ
When is Absci (ABSI) presenting at the KeyBanc Capital Markets Healthcare Forum 2025?
How can investors watch Absci's (ABSI) KeyBanc Healthcare Forum presentation?
What type of presentation will Absci (ABSI) deliver at the KeyBanc Healthcare Forum?
Is the KeyBanc Capital Markets Healthcare Forum where Absci (ABSI) is presenting an in-person event?
